Results 161 to 170 of about 627 (172)

4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease

Lancet, The, 1999
Jan A Hazelzet, Michael Levin
exaly  

C1-ESTERASE INACTIVATORS AND C4 IN MALIGNANT DISEASES

Lancet, The, 1975
exaly  

ACUTE PULMONARY EMBOLISM TREATED WITH TISSUE PLASMINOGEN ACTIVATOR

Lancet, The, 1986
Joseph Loscalzo
exaly  

PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION

Lancet, The, 1987
exaly  

ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction

Lancet, The, 1992
exaly  

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

Lancet, The, 1993
exaly  

SPECIFIC LYSIS OF AN ILIOFEMORAL THROMBUS BY ADMINISTRATION OF EXTRINSIC (TISSUE-TYPE) PLASMINOGEN ACTIVATOR

Lancet, The, 1981
exaly  

Diversity and Modulation of Plasminogen Activator Activity in Human Transitional Carcinoma Cell Lines

Journal of Urology, 1994
exaly  

Suicide enzyme inactivators

Accounts of Chemical Research, 1976
exaly  

TREATMENT OF DEEP-VEIN THROMBOSIS WITH INTERMITTENT STREPTOKINASE AND PLASMINOGEN INFUSION

Lancet, The, 1975
exaly